The Cooper Companies, Inc. (NASDAQ:COO) Stock Position Increased by EverSource Wealth Advisors LLC

EverSource Wealth Advisors LLC boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 4.9% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,611 shares of the medical device company’s stock after buying an additional 264 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in Cooper Companies were worth $524,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Vanguard Group Inc. boosted its stake in shares of Cooper Companies by 303.0% during the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after buying an additional 17,367,502 shares during the period. Kayne Anderson Rudnick Investment Management LLC grew its stake in shares of Cooper Companies by 3.0% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 7,820,590 shares of the medical device company’s stock worth $682,738,000 after acquiring an additional 231,155 shares during the last quarter. Capital World Investors increased its holdings in shares of Cooper Companies by 301.7% during the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after purchasing an additional 4,246,519 shares during the period. Janus Henderson Group PLC increased its position in shares of Cooper Companies by 279.8% during the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock valued at $348,723,000 after purchasing an additional 2,532,186 shares during the period. Finally, Impax Asset Management Group plc raised its stake in shares of Cooper Companies by 31.0% in the second quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock valued at $205,511,000 after purchasing an additional 558,886 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at $18,267,624.69. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now directly owns 6,614 shares in the company, valued at approximately $700,422.60. The disclosure for this sale can be found here. Insiders have sold 256,373 shares of company stock worth $27,637,427 in the last quarter. Insiders own 2.00% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO stock opened at $109.81 on Tuesday. The stock has a market capitalization of $21.87 billion, a PE ratio of 64.59, a PEG ratio of 2.60 and a beta of 0.98. The Cooper Companies, Inc. has a one year low of $75.93 and a one year high of $112.38. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The business’s 50 day simple moving average is $98.35 and its 200 day simple moving average is $95.51.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.84 earnings per share. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.66 earnings per share for the current year.

Analyst Upgrades and Downgrades

COO has been the topic of a number of recent analyst reports. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and boosted their price target for the company from $107.00 to $115.00 in a research report on Tuesday, July 16th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Morgan Stanley increased their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 10th. Robert W. Baird boosted their price objective on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Finally, Wells Fargo & Company increased their price target on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $115.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.